Compare Angi Inc (ANGI) vs Marsh & McLennan Companies, Inc. (MRSH) Price & Performance

ANGI trades at $4.315, down 5.99% in the last session, reflecting ongoing operational challenges. The stock shows bearish technical signals with support near $4.00 and resistance at $5.00. Recent Q2 2026 earnings missed expectations with a significant EPS loss of $5.70, while revenue declined 11% year-over-year. Despite a low P/E of 14.81 and P/S of 0.19, negative net income margin of -22.35% and ROE of -26.25% highlight profitability struggles. Analyst consensus remains mixed with a $7.00 price target but accelerating pro user churn and legal investigations cloud the outlook.

The outlook for ANGI is cautious due to declining revenue, persistent losses, and competitive pressures. Investment opportunity exists if the company successfully executes its AI pivot and stabilizes user engagement, but risks include ongoing legal probes, high debt, and market share erosion. Near-term volatility is likely amid weak fundamentals and negative sentiment.

Marsh & McLennan (MRSH) trades at $188.81, down 1.04% today, but maintains a bullish technical trend with strong fundamentals. The company reported Q2 2026 EPS of $2.96, beating estimates, and has consistently exceeded earnings expectations. Revenue growth remains solid at 6% in Q2 2026, driven by risk and consulting services. Recent acquisitions, like the planned purchase of Accel Holdings, aim to expand its Midwest insurance reach.

The outlook is positive with a consensus price target of $202.89, suggesting 7.5% upside. Risks include margin pressure from rising expenses and soft P&C pricing. Analyst sentiment is mixed with 30.3% buy ratings but 66.7% hold, indicating cautious optimism. Institutional activity shows new positions by Ashton Thomas Securities and Bank of Nova Scotia, supporting long-term growth prospects.